Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.73 |
| ▸ | RAB9A | P51151 | 2/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.73 |
| ▸ | HPGD | P15428 | 1/20 | 0.73 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.65 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.64 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.64 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.64 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | RXRA | P19793 | 1/20 | 0.61 |
| ▸ | ATM | Q13315 | 1/20 | 0.59 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL184987 | 0.94 | SMPD1 (0.71) | NPC1RAB9ASMN1; SMN2HPGDMRGPRX4 | |
| SCHEMBL29557477 | 0.91 | HPGD (0.59) | NPC1RAB9ASMN1; SMN2HPGDMRGPRX4 | |
| SCHEMBL1599431 | 0.91 | HPGD (0.59) | NPC1RAB9ASMN1; SMN2HPGDMRGPRX4 | |
| SCHEMBL20463492 | 0.89 | MRGPRX4 (0.65) | NPC1RAB9ASMN1; SMN2HPGDMRGPRX4 | |
| SCHEMBL242563 | 0.88 | MRGPRX4 (0.77) | NPC1RAB9ASMN1; SMN2HPGDMRGPRX4 | |
| SCHEMBL27881765 | 0.88 | NPC1 (0.77) | NPC1RAB9ASMN1; SMN2HPGDMRGPRX4 | |
| SCHEMBL3944668 | 0.87 | MRGPRX4 (0.59) | NPC1RAB9ASMN1; SMN2HPGDMRGPRX4 | |
| SCHEMBL31025721 | 0.87 | NPC1 (0.75) | NPC1RAB9ASMN1; SMN2HPGDMRGPRX4 | |
| SCHEMBL340620 | 0.87 | NPC1 (0.75) | NPC1RAB9ASMN1; SMN2HPGDMRGPRX4 | |
| SCHEMBL11277266 | 0.87 | MRGPRX4 (0.75) | NPC1RAB9ASMN1; SMN2HPGDMRGPRX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3580389-B1 | NOVEL METHODS FOR PROCESSING LIGNOCELLULOSIC MATERIAL | CMBLU ENERGY AG (DE) | 2025-09-17 | — | — | EP | disclosed |
| EP-3580302-B1 | REDOX FLOW BATTERY ELECTROLYTES | CMBLU ENERGY AG (DE) | 2025-09-17 | — | — | EP | disclosed |
| US-20250192176-A1 | Redox Flow Battery Electrolytes | CMBLU ENERGY AG (DE) | 2025-06-12 | — | — | US | disclosed |
| US-20240356030-A1 | Redox Flow Battery Electrolytes | CMBLU ENERGY AG (DE) | 2024-10-24 | — | — | US | disclosed |
| US-20240318382-A1 | Sulfonated Lignin-Derived Compounds And Uses Thereof | CMBLU ENERGY AG (DE) | 2024-09-26 | — | — | US | disclosed |
| US-11891349-B2 | Aminated lignin-derived compounds and uses thereof | CMBLU ENERGY AG (DE) | 2024-02-06 | — | — | US | disclosed |
| US-11831017-B2 | Redox flow battery electrolytes | CMBLU ENERGY AG (DE) | 2023-11-28 | — | — | US | disclosed |
| US-11831017-B2 | Redox flow battery electrolytes | CMBLU ENERGY AG (DE) | 2023-11-28 | — | — | US | disclosed |
| US-11831017-B2 | Redox flow battery electrolytes | CMBLU ENERGY AG (DE) | 2023-11-28 | — | — | US | disclosed |
| US-11788228-B2 | Methods for processing lignocellulosic material | CMBLU ENERGY AG (DE) | 2023-10-17 | — | — | US | disclosed |
| EP-0635480-B1 | Anthracene derivatives | WAKO PURE CHEM IND LTD (JP) | 1997-03-19 | — | — | EP | disclosed |
| CN-1137895-A | Prevention and curing agent for c attenuation living vaccine | EISAI CO LTD (JP) | 1996-12-18 | — | — | CN | disclosed |
| US-5576359-A | ANTHRACENE DERIVATIVE, SOLVENT, COMPOUND CONTAINING GLYCIDYL GROUPS | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 1996-11-19 | — | — | US | disclosed |
| EP-0636941-B1 | Deep ultraviolet absorbent and its use in pattern formation | WAKO PURE CHEM IND LTD (JP) | 1996-03-20 | — | — | EP | disclosed |
| US-5498748-A | PHENOLIC CROSSLINKER FOR A POLYGLYCIDYL METHACRYLATE TO FORM A MATERIAL USED AS AN ANTIREFLECTION COATING FOR DEEP UV LIGHT SUCH AS KRF EXIMER LASERS IN SEMICONDUCTOR PHOTORESISTS | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 1996-03-12 | — | — | US | disclosed |
| EP-0636941-A1 | Deep ultraviolet absorbent and its use in pattern formation | WAKO PURE CHEMICAL INDUSTRIES LTD (JP) | 1995-02-01 | — | — | EP | disclosed |
| EP-0635480-A1 | Anthracene derivatives | WAKO PURE CHEMICAL INDUSTRIES LTD (JP) | 1995-01-25 | — | — | EP | disclosed |
| EP-0613879-A1 | PHELLODENDRINE ANALOGS AND ALLERGY TYPE IV SUPPRESSOR CONTAINING THE SAME AS ACTIVE INGREDIENT | TSUMURA & CO. (JP) | 1994-09-07 | — | — | EP | disclosed |
| US-4618680-A | ANTIARRHYTHMIA AGENTS | MEAD JOHNSON & COMPANY (US) | 1986-10-21 | — | — | US | disclosed |
| US-4332803-A | ANTIARRHYTHMIA AGENTS | MEAD JOHNSON & COMPANY (US) | 1982-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240356030-A1 | Redox Flow Battery Electrolytes | GPX4, GPX1, MPO | NPC1 3816/4885RAB9A 747/4885SMN1; SMN2 3204/4885 |
| US-11788228-B2 | Methods for processing lignocellulosic material | DCXR, LCT, AGL | NPC1 2208/4885RAB9A 4443/4885SMN1; SMN2 4294/4885 |
| US-11891349-B2 | Aminated lignin-derived compounds and uses thereof | NQO1, DCXR, NOX4 | NPC1 4192/4885RAB9A 2645/4885SMN1; SMN2 4488/4885 |
| US-11831017-B2 | Redox flow battery electrolytes | GPX1, GPX4, NOX4 | NPC1 3240/4885RAB9A 1347/4885SMN1; SMN2 4095/4885 |
| US-20250192176-A1 | Redox Flow Battery Electrolytes | GPX1, GPX4, CYBB | NPC1 3781/4885RAB9A 570/4885SMN1; SMN2 3297/4885 |
| US-20240318382-A1 | Sulfonated Lignin-Derived Compounds And Uses Thereof | SQOR, NQO1, NOX4 | NPC1 4337/4885RAB9A 3114/4885SMN1; SMN2 3589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.